Size alone is not enough: Ki-67 and invasion patterns identify high-risk pancreatic neuroendocrine tumors (pNETs)
DOI:
https://doi.org/10.1590/0102-672020260000027e1956Keywords:
Neuroendocrine Tumors, Surgical Oncology, Pancreas, PancreatectomyAbstract
Background: Pancreatic neuroendocrine tumors (pNETS) constitute a heterogeneous and rare disease worldwide. Diagnosis has been increasing, and the evaluation of prognostic factors has become even more important in the treatment decision process. Aims: To present results and prognostic factors in patients undergoing surgical treatment for pNETS in a single Brazilian center.
Results: The most performed surgical procedure was corpus-caudal pancreatectomy with splenectomy 60.0%. The median hospital stay was 8 (5-13) days, and postoperative mortality occurred in 1.7%. Overall survival in 3 and 5 years was 93.8% and 92.1%. Disease-free survival at 3 and 5 years was 87.1% and 71.8%. Patients with tumors smaller than 2.0 cm did not present with lymph node disease or recurrence and 2.1-2.5cm individuals had lymph node disease in 11.1% and recurrence in 11.1%. In univariate and multivariate analysis, the presence of lymphatic and perineural vascular invasion and Ki67 (3-20) were strongly correlated with positive lymph node disease and recurrence, respectively.
Conclusions: The presence of lymphatic and perineural vascular invasion, Ki67 (3 to 20), and tumors above 2.5 cm correlated with positive lymph node disease and recurrence.
Downloads
Posted
How to Cite
Section
Copyright (c) 2026 Dante Altenfelder Silva Mesquita Cortelli, Silvio Melo Torres, Igor Correia de Farias, Alessandro Landskron Diniz, Heber Salvador de Castro Ribeiro, André Luis de Godoy, Caroline Almeida Gonçalves, Felipe José Fernández Coimbra

This work is licensed under a Creative Commons Attribution 4.0 International License.
Plaudit
Data statement
-
The research data is available on demand, condition justified in the manuscript


